“showed a trend”

Although the mean sonographic lesion size in the NAC group showed a trend of being larger than that in the non-NAC group, there was no significant difference between the two groups (P=0.36).

PARP inhibitors combined with chemotherapy significantly improved PFS (hazard ratio [HR] 0.73, 95% confidence interval [CI] 0.63-0.84, P < .0001) and showed a trend towards improved OS (HR 0.93, 95% CI 0.79-1.09, P = .36), though this was not statistically significant.

Generally, the expression level of SLCO1B3 showed a trend of decreasing throughout the laying cycle ( P -value = 0.36) ( Figure 2 ).

Consistent with its negative association with AS and the levels of LDL-C and TG, garlic also showed a trend to be negatively associated with CRP (OR = 0.974, p = 0.361, Figure 5 ).

The joinpoint analysis reports that Brazil showed a trend towards stability in the incompleteness of the race/color variable in COVID-19 hospitalizations (AMPC = 0.54; 95%CI: -0.64 to 1.74; p = 0.37) ( Table 2 ).

The chemokine CCL5/RANTES showed a trend to increase in TSHR-immunized compared with βgal only in ddH 2 O treated mice ( P = 0.37) whilst IL-4 was significantly higher in TSHR-ddH 2 O-compared with βgal ( P = 0.0170) (Fig. 6 c).

At 72 hr post-HII, total lesion volumes showed a trend toward reduction in HT compared with NT pups (42%; p = .37) as did the penumbra (53%; p = .25) with little change in the ischemic core (16%; p = .77).

Despite the non-significant difference (MD = -0.05; 95% CI: -0.17 to 0.07) (z = -0.77, p = 0.44), the results showed a trend toward experimental groups with neglected heterogeneity (Q (9) = 9.77, p = 0.37, tau 2 = 0.0001, I 2 = 0.34%).

This difference remained significant for patients with ASXL1 mutations (n=29; survival 29 vs 12 months; p=0.026) while patients with mutations in EZH2 (n=12) showed a trend towards longer survival (20 vs 14 months; p=0.37).

While the density of small arterioles (<50 μm) showed a trend toward increase following the miR-320 knockdown, this was not significant (25 ± 9/mm 2 in db/db + LNA-premiR-320 versus 17 ± 3/mm 2 in db/db + LNA-Scr, p = 0.37; Figures 5 G and S8 ).

GTR or CTR resection had significantly better 5-year OS [p = 0.45; HR = 0.56 (95% CI, 0.43–0.72); I 2 = 0%] and 5-year EFS [ p = 0.15; HR = 0.80 (95% CI, 0.71–0.90); I 2 = 31%] than subtotal tumor resection (STR) or biopsy only; however, both CTR or GTR showed a trend for more intra and post-operative complications compared with the STR or biopsy only [ p = 0.37; OR = 1.54 (95% CI, 1.08–2.20); I 2 = 0%].

In mice the first treatment group with tumor xenograft implants did not show any significant anti-tumor activity but showed a trend where higher dose group had smaller tumor volumes as compared to lower dose group and controls (p = 0.37 and p = 0.34 respectively).

Both miRNAs, miR-891b and miR-138-5p showed a trend of negative correlation with EGFR-AS1 levels (r = − 0.214, p = 0.3789 and r = − 0.191, p = 0.235, respectively) (Fig. 4 c,d).

According to Figure 3A,D , patients with low LIPG expression showed a trend of better OS ( p = 0.38 and p = 0.13).

Those on HAART who had two or more living children showed a trend to want to continue childbearing than those who were not on HAART (18.2% vs. 7.9%, p = 0.380).

Studies on non‐viable cysts showed a trend towards lesion resolution favouring anthelmintic drugs (72% versus 63%; P = 0.38), but this was not significant unless an outlying trial was excluded (69% versus 55%; P = 0.006).

Similarly, viral load levels at baseline did not significantly differ between groups, although patients with HIV viral loads <1000 showed a trend toward lower odds of having AD compared with those with viral loads >1000 (adjusted OR:0.58; 95%CI: 0.17–2.00; P = .38).

First, in the 129 patients with platinum-based chemotherapy, sick persons with a low pyroptosis points showed a trend of a higher survival rate than sick persons with a high pyroptosis points, all of whom were subjected to chemotherapy ( p = 0.38; Fig. 7 A).

The subgroup analysis showed a trend of patients with brain metastases benefit from TRT (21.8 versus 13.7 months, HR 0.61, p = 0.38) while liver metastases did not.

Although younger individuals showed a trend toward higher noncalcified plaque volume, the difference was not statistically significant (140.59 ± 130.34 mm 3 vs 133.02 ± 122.00 mm 3 , P = .38).

Although there were no statistically significant differences in the length of hospital stay, the experimental group showed a trend toward shorter stays (9.85 days vs. 11.65 days; p = 0.38) and lower analgesic consumption (13.01 doses vs. 21.15 doses; p = 0.09).

Notably, PR expression was lower in EOCs than in nonadjacent normal epithelial tissues; however, its overexpression in EOCs showed a trend toward poor DFS ( p = 0.384; Figure 1 D). 2.2.

Tumors from C134- and C335-treated mice also showed a trend toward a decreased percentage of Ki-67-positive cells ( p = 0.384 for C134 vs. vehicle and p = 0.142 for C335 vs vehicle, Additional file 8 : Figure S6B-C).

The correlation analysis between TL and honeycombing extent showed a trend of a negative correlation of TL with the percentage of tissue exhibiting a honeycombing appearance within the entire lung (Rho = -0.131, p = 0.387; Fig. 3A ), but there was no significant association between them.

However, altered gene expression showed a trend toward better prognosis in anti-PD-1 treatment ( P = 0.387, Fig. 4 E), though this did not reach statistical significance.